| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
332,180,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.78 - $0.78 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cardiovascular Systems is a medical technology company. Co. has developed a patented orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. Co.'s peripheral artery disease products are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee, including calcified plaque, and address various limitations associated with other existing surgical, catheter and pharmacological treatment alternatives. Co.'s coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS, is a catheter-based platform designed to facilitate stent delivery in patients with CAD.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$86,963 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Egeland Ryan |
Chief Medical Officer |
• – – |
2020-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
20,660 |
66,059 |
|
- |
|
| Hastings John M. |
VP Manufacturing & Operations |
• – – |
2020-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
17,384 |
46,654 |
|
- |
|
| Robb Rhonda J. |
Chief Operating Officer |
• – – |
2020-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
48,631 |
166,106 |
|
- |
|
| Cohn William E. |
Director |
– • – |
2020-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,768 |
4,376 |
|
- |
|
| Rempe Stephen J. |
Chief Human Resources Officer |
• – – |
2020-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
18,644 |
30,463 |
|
- |
|
| Stenbeck Stephen |
Director |
– • – |
2020-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,154 |
3,153 |
|
- |
|
| Whitescarver David |
VP of Corp. Dev. and IP |
• – – |
2020-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
18,956 |
51,408 |
|
- |
|
| Lawlor Augustine |
Director |
– • – |
2020-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,090 |
27,408 |
|
- |
|
| Points Jeffrey S. |
Chief Financial Officer |
• – – |
2020-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
34,228 |
84,841 |
|
- |
|
| Rempe Stephen J. |
Chief Human Resources OfficerO |
• – – |
2020-07-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,819 |
|
- |
|
| Robb Rhonda J. |
Chief Operating Officer |
• – – |
2020-02-12 |
4 |
D |
$42.02 |
$127,531 |
D/D |
(3,035) |
117,475 |
|
- |
|
| Robb Rhonda J. |
Chief Operating Officer |
• – – |
2020-02-12 |
4 |
S |
$42.29 |
$152,246 |
D/D |
(3,600) |
120,510 |
|
- |
|
| Rosenstein Alexander |
General Counsel & Corp. Sec. |
• – – |
2020-02-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
709 |
67,688 |
|
- |
|
| Rosenstein Alexander |
General Counsel & Corp. Sec. |
• – – |
2020-02-12 |
4 |
S |
$42.18 |
$147,627 |
D/D |
(3,500) |
68,379 |
|
- |
|
| Hastings John M. |
VP Manufacturing & Operations |
• – – |
2020-02-12 |
4 |
S |
$42.11 |
$225,585 |
D/D |
(5,357) |
29,173 |
|
- |
|
| Points Jeffrey S. |
Chief Financial Officer |
• – – |
2020-02-12 |
4 |
S |
$42.18 |
$126,536 |
D/D |
(3,000) |
50,613 |
|
- |
|
| Hastings John M. |
VP Manufacturing & Operations |
• – – |
2019-11-12 |
4 |
D |
$43.94 |
$41,919 |
D/D |
(954) |
34,352 |
|
- |
|
| Points Jeffrey S. |
Chief Financial Officer |
• – – |
2019-11-12 |
4 |
D |
$43.94 |
$27,946 |
D/D |
(636) |
54,668 |
|
- |
|
| Egeland Ryan |
Chief Medical Officer |
• – – |
2019-11-12 |
4 |
D |
$43.94 |
$50,267 |
D/D |
(1,144) |
45,399 |
|
- |
|
| Sedo Sandra |
Chief Compliance Officer |
• – – |
2019-11-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,611 |
53,590 |
|
- |
|
| Whitescarver David |
VP of Corp. Dev. and IP |
• – – |
2019-11-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,611 |
31,531 |
|
- |
|
| Blackey Brent G |
Director |
– • – |
2019-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,095 |
94,332 |
|
- |
|
| Rosenstein Alexander |
General Counsel & Corp. Sec. |
• – – |
2019-08-29 |
4 |
AS |
$50.42 |
$318,025 |
D/D |
(6,308) |
71,879 |
|
- |
|
| Rosenstein Alexander |
General Counsel & Corp. Sec. |
• – – |
2019-08-28 |
4 |
D |
$50.14 |
$31,638 |
D/D |
(631) |
78,187 |
|
- |
|
| Ward Scott R |
Chairman and CEO |
• • – |
2019-08-28 |
4 |
D |
$50.14 |
$213,446 |
D/D |
(4,257) |
425,268 |
|
- |
|
413 Records found
|
|
Page 7 of 17 |
|
|
